Michael Okunewitch

Stock Analyst at Maxim Group

(0)
# 4997
Out of 5,441 analysts
29
Total ratings
Success rate
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
ANEB Anebulo Pharmaceutic...
Downgrades: Hold
n/a
n/a n/a 3 Jul 23, 2025
HCWB HCW Biologics
Maintains: Buy
120 35
4.37 700.92% 2 May 29, 2025
CTOR Citius Oncology
Downgrades: Hold
n/a
n/a n/a 2 May 23, 2025
RADX Radiopharm Theranost...
Initiates Coverage On: Buy
12
4.49 167.26% 1 May 1, 2025
CMMB Chemomab Therapeutic...
Maintains: Strong Buy
4 7
0.95 636.84% 2 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
1.49 839.6% 1 Feb 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 3
1 200% 1 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
0.98 308.16% 1 Oct 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
0.55 2081.82% 1 Sep 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 6
0.7 757.14% 2 Aug 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
3 12
0.82 1363.41% 2 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
2
n/a n/a 1 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
1.22 1867.21% 1 Oct 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
108 18
2.44 637.7% 3 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
2025
2.39 84628.03% 1 Apr 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
18.81 32.91% 1 Dec 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.43 319.58% 1 Sep 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
n/a n/a 1 Feb 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
3.96 531.31% 1 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
100
1.25 7900% 1 Nov 30, 2021